Power Law company profile

Structure Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2016 · IPO 2023 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.50B

Market cap · Apr/2026

Investors

12 investors on Structure Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Series B+ 10 investors entered at this stage

Global footprint

AI talent share

1.0% of workforce is AI talent
(2 of 202 staff)

Core AI10.5%

Other AI10.5%

Non-AI workforce20099.01%

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States53.8%

🏳️ Korea22.9%

🏳️ Republic of9.6%

🇫🇷 France9.2%

🇬🇧 United Kingdom3.3%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo